Abstract
Objective: This study represents head and neck cancer patient’s care at Departement of Otorhinolaryngology-Head and Neck Surgery (ORL-HNS) in Hasan Sadikin General Hospital during COVID-19 pandemic.
 Methods: The study is done using a retrospective descriptive method based on medical record data in patients with head and neck cancer at Oncology Departement of ORL-HNS, Hasan Sadikin General Hospital, Bandung from March to July 2020. Samples were selected with total sampling. All existing subjects who met the study criteria were enrolled. The inclusion criteria in this study were head and neck cancer patients from March to July 2020. The exclusion criteria were incomplete medical records data.
 Results: The number of outpatient visits at ORL-HNS Departement, Dr. Hasan Sadikin General Hospital Bandung from March to July was 3723 patients with 1796 of them are oncology outpatients. There was a significant decrease in the number of ORL-HNS outpatient in April and May and began to increase steadily in June and July. This is in line with the start of the big-scale social restriction at the end of March and the start of the ‘new normal’ era in early June.
 Conclusion: The study demonstrates the significant impact of the COVID-19 crisis on oncological care. During COVID-19 pandemic, the treatment of HNC patients has been severely disrupted and caused a decrease in the number of procedures at Dr. Hasan Sadikin General Hospital Bandung.
Highlights
The world at this time was affected by the novel Coronavirus disease (COVID-19) that first started in the city of Wuhan, Hubei province, China
For Otorhinolaryngology-Head and Neck Surgery (ORL-HNS) oncology patients, there was a decrease in outpatients by 58% in April and 66% in May compared to February
The number of outpatients started to increase in June with the addition of outpatients by more than 100% in ORL-HNS Outpatient and 43% in ORL-HNS oncology outpatient
Summary
The world at this time was affected by the novel Coronavirus disease (COVID-19) that first started in the city of Wuhan, Hubei province, China. The World Health Organization (WHO) facilitates the worldwide effort to deal with the effects and it declared COVID-19 as a global pandemic on March 11, 2020 [1]. At the point when the novel Covid SARS-CoV2 hit China most seriously during the long periods of December 2019–February 2020. Indonesia reported no case of infection at all. On March 2, 2020, the government announced two confirmed cases of COVID-19. As of September 25, 2020, the country has reached 262.022 confirmed cases, 4823 new cases, with 10105 number of deaths, and 4343 number of recoveries with overall positive rate is 14,34% [1, 2]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmacy and Pharmaceutical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
